scholarly journals MACRONUTRIENT SUPPLEMENTS IN PRETERM OR SMALL‐FOR‐GESTATIONAL‐AGE ANIMALS; A SYSTEMATIC REVIEW AND META‐ANALYSIS

2019 ◽  
Vol 55 (S1) ◽  
pp. 57-57
Keyword(s):  
Systematic Review ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Meta Analysis

Premature birth, low birth weight, small for gestational age and chronic non-communicable diseases in adult life: A systematic review with meta-analysis

2020 ◽  
Vol 149 ◽  
pp. 105154 ◽  
Author(s):  
Elaine Luiza Santos Soares de Mendonça ◽  
Mateus de Lima Macêna ◽  
Nassib Bezerra Bueno ◽  
Alane Cabral Menezes de Oliveira ◽  
Carolina Santos Mello
Keyword(s):  
Systematic Review ◽  
Birth Weight ◽  
Low Birth Weight ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Premature Birth ◽  
Meta Analysis ◽  
Adult Life ◽  
Communicable Diseases ◽  
Non Communicable Diseases

scholarly journals Children Born with Congenital Heart Defects and Growth Restriction at Birth: A Systematic Review and Meta-Analysis

2020 ◽  
Vol 17 (9) ◽  
pp. 3056 ◽  
Author(s):  
Ali Ghanchi ◽  
Neil Derridj ◽  
Damien Bonnet ◽  
Nathalie Bertille ◽  
Laurent J. Salomon ◽  
...  
Keyword(s):  
Systematic Review ◽  
Congenital Heart Defects ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Congenital Heart ◽  
Heart Defects ◽  
Data Extraction ◽  
Meta Analysis ◽  
Adverse Outcomes ◽  
Growth Restriction

Newborns with congenital heart defects tend to have a higher risk of growth restriction, which can be an independent risk factor for adverse outcomes. To date, a systematic review of the relation between congenital heart defects (CHD) and growth restriction at birth, most commonly estimated by its imperfect proxy small for gestational age (SGA), has not been conducted. Objective: To conduct a systematic review and meta-analysis to estimate the proportion of children born with CHD that are small for gestational age (SGA). Methods: The search was carried out from inception until 31 March 2019 on Pubmed and Embase databases. Studies were screened and selected by two independent reviewers who used a predetermined data extraction form to obtain data from studies. Bias was assessed using the Critical Appraisal Skills Programme (CASP) checklist. The database search identified 1783 potentially relevant publications, of which 38 studies were found to be relevant to the study question. A total of 18 studies contained sufficient data for a meta-analysis, which was done using a random effects model. Results: The pooled proportion of SGA in all CHD was 20% (95% CI 16%–24%) and 14% (95% CI 13%–16%) for isolated CHD. Proportion of SGA varied across different CHD ranging from 30% (95% CI 24%–37%) for Tetralogy of Fallot to 12% (95% CI 7%–18%) for isolated atrial septal defect. The majority of studies included in the meta-analysis were population-based studies published after 2010. Conclusion: The overall proportion of SGA in all CHD was 2-fold higher whereas for isolated CHD, 1.4-fold higher than the expected proportion in the general population. Although few studies have looked at SGA for different subtypes of CHD, the observed variability of SGA by subtypes suggests that growth restriction at birth in CHD may be due to different pathophysiological mechanisms.

Inadequate weight gain in obese women and the risk of small for gestational age (SGA): a systematic review and meta-analysis

2016 ◽  
Vol 30 (3) ◽  
pp. 357-367 ◽  
Author(s):  
Zhou Xu ◽  
Zhenxing Wen ◽  
Yuhan Zhou ◽  
Duanhua Li ◽  
Zhongli Luo
Keyword(s):  
Systematic Review ◽  
Weight Gain ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Meta Analysis ◽  
Obese Women

Association Between Factor V Leiden Mutation, Small for Gestational Age, and Preterm Birth: A Systematic Review and Meta-Analysis

2016 ◽  
Vol 38 (10) ◽  
pp. 897-908 ◽  
Author(s):  
Erin M. Hemsworth ◽  
Amanda M. O'Reilly ◽  
Victoria M. Allen ◽  
Stefan Kuhle ◽  
Jo-Ann K. Brock ◽  
...  
Keyword(s):  
Systematic Review ◽  
Preterm Birth ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Meta Analysis ◽  
Factor V Leiden ◽  
Factor V ◽  
Factor V Leiden Mutation

scholarly journals Maternal Antioxidant Levels in Pregnancy and Risk of Preeclampsia and Small for Gestational Age Birth: A Systematic Review and Meta-Analysis

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0135192 ◽  
Author(s):  
Jacqueline M. Cohen ◽  
Margaret Beddaoui ◽  
Michael S. Kramer ◽  
Robert W. Platt ◽  
Olga Basso ◽  
...  
Keyword(s):  
Systematic Review ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Meta Analysis ◽  
In Pregnancy ◽  
Risk Of Preeclampsia

Association of small for gestational age with retinopathy of prematurity: a systematic review and meta-analysis

2019 ◽  
Vol 105 (3) ◽  
pp. 270-278 ◽  
Author(s):  
Abdul Razak ◽  
Maher Faden
Keyword(s):  
Systematic Review ◽  
Preterm Infants ◽  
Gestational Age ◽  
Retinopathy Of Prematurity ◽  
Small For Gestational Age ◽  
Neonatal Intensive Care ◽  
Web Of Science ◽  
Meta Analysis ◽  
Screening Guidelines ◽  
Newcastle Ottawa Scale

ContextThe association between small for gestational age (SGA) and retinopathy of prematurity (ROP) is unclear.ObjectiveA systematic review and meta-analysis was conducted to evaluate the association between ROP and SGA in preterm infants <37 weeks’ gestational age (GA) admitted to neonatal intensive care unit.MethodsMedline, PubMed, Web of Science and Cochrane Central databases were searched from inception through 15 January 2019. Studies reporting outcomes based on SGA as the primary exposure variable were included. Data were extracted independently by two coauthors. Modified Newcastle-Ottawa scale was used for risk of bias assessment.ResultsDatabase search yielded 536 records (Medline=152, PubMed=171, Web of Science=144 and Cochrane Central=69). Twenty-one studies evaluating 190 946 infants were included. SGA was associated with significantly higher odds of any stage of ROP on unadjusted analysis (unadjusted OR (uOR) 1.55; 95% CI 1.22 to 1.98; 10 studies) but not on adjusted analysis (adjusted OR (aOR) 2.16; 95% CI 0.66 to 7.11; 3 studies). SGA was associated with significantly higher odds of severe ROP (aOR 1.92; 95% CI 1.57 to 2.34; nine studies). SGA was also significantly associated with higher odds of treated ROP (aOR 1.39; 95% CI 1.18 to 1.65; three studies). In subgroup analysis of infants <29 weeks’ GA, SGA was significantly associated with increased odds of ROP (uOR 1.64; 95% CI 1.19 to 2.26; two studies), severe ROP (aOR 1.61; 95% CI 1.23 to 2.10; four studies) and treated ROP (aOR 1.37; 95% CI 1.16 to 1.62; two studies).ConclusionSGA was associated with increased odds of any stage of ROP, severe ROP and treated ROP in preterm infants. Neonatologists should incorporate SGA into the risk assessment during ROP evaluation and while providing counselling to the families of preterm SGA infants. ROP screening guidelines should look into the frequency of follow-up examination in SGA infants in aim to offer early detection and treatment.

Sign in / Sign up

Export Citation Format

Share Document